The Radboud University Medical Center, is the teaching hospital affiliated with the Radboud University Nijmegen, in the city of Nijmegen in the eastern-central part of the Netherlands. The Radboud University Medical Center was founded in 1956.

There are 1,065 beds in Radboud University Medical Centre.

During the past decade, Radboud University Medical Centre conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 4 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Radboud University Medical Centre" #1 sponsor was "Radboud University Medical Center" with 38 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 13 trials sponsored, "Amsterdam UMC, location VUmc" with 3 trials sponsored, "Oticon Medical" with 3 trials sponsored and "UMC Utrecht" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radboud University Medical Centre" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 9 trials as a collaborator, "Radboud University Medical Center" with 5 trials as a collaborator, "Dutch Cancer Society" with 4 trials as a collaborator, "Leiden University Medical Center" with 4 trials as a collaborator and "Erasmus Medical Center" with 3 trials as a collaborator. Other collaborators include 112 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "Radboud University Medical Centre" are "Coronary Artery Disease" (4 trials), "Duchenne Muscular Dystrophy" (3 trials), "Mesothelioma" (3 trials), "Non Small Cell Lung Cancer" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Radboud University Medical Centre" in a lesser frequency.

Most popular intervention types in "Radboud University Medical Centre" are "Drug" (44 trials), "Other" (14 trials), "Procedure" (13 trials), "Device" (10 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Pemetrexed" (3 trials), "placebo" (3 trials), "Brentuximab Vedotin" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Radboud University Medical Centre" are 79 trials for "All" genders, 8 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 30 active trials in "Radboud University Medical Centre". 2 are not yet recruiting, 17 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in Radboud University Medical Centre, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Radboud University Medical Centre, 6 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 23 trials that are defined as “Not Applicable".